This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries, Expert Review of Vaccines, May 2017, Taylor & Francis,
DOI: 10.1080/14760584.2017.1324302.
You can read the full text:
Be the first to contribute to this page
Journal of Cardiothoracic Surgery
This randomized controlled trial is to assess the potential effect of Tocovid, a tocotrienol-rich Vitamin E, derived from palm oil, in reducing the most common problem after coronary artery bypass ...
Therapeutics and Clinical Risk Management
This review features emerging treatment options for cancer-associated cachexia including promising new agents, and multidrug as well as multimodal approaches tested in the past or on-going RCTs.
BMC Musculoskeletal Disorders
This clinical trial tested if arthritis gloves work. Previously, we reviewed published evidence about arthritis glove effects. We found little evidence to say they work. Arthritis gloves aim to re...
